capital and assist management in building and commercializing breakthrough diagnostic and
therapeutic products in the fields of life sciences, while providing superior returns to our
ETP supports our portfolio companies facilitate strategic alliances including cross-border
partnerships, recruit management, and acquire new products and technologies to accelerate
growth in both US and China. We have investment partners in San Francisco, Boston,
Washington DC, and Beijing.